n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine and 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide

n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine has been researched along with 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Befort, K; Décaillot, FM; Filliol, D; Kieffer, BL; Lazarus, LH; Schiller, PW; Schmidhammer, H; Tryoen-Tóth, P	1

Other Studies

1 other study(ies) available for n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine and 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide

Article	Year
Inverse agonism and neutral antagonism at wild-type and constitutively active mutant delta opioid receptors. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 313, Issue:1 Topics: Alkaline Phosphatase; Benzamides; Cell Line; Dipeptides; Dose-Response Relationship, Drug; Enkephalin, Leucine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Mutation; Naltrexone; Narcotic Antagonists; Piperazines; Receptors, Opioid, delta; Structure-Activity Relationship	2005

Article

Year

Inverse agonism and neutral antagonism at wild-type and constitutively active mutant delta opioid receptors.

The Journal of pharmacology and experimental therapeutics, 2005, Volume: 313, Issue:1

Topics: Alkaline Phosphatase; Benzamides; Cell Line; Dipeptides; Dose-Response Relationship, Drug; Enkephalin, Leucine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Mutation; Naltrexone; Narcotic Antagonists; Piperazines; Receptors, Opioid, delta; Structure-Activity Relationship

2005